glp 1 severe diarrhea Ozempic: Semaglutide is a GLP-1 receptor agonist used for type 2 diabetes and cardiovascular risk reduction in selected patients, commonly causing nausea, vomiting, diarrhea, constipation, abdominal pain, reduced appetite, and weight loss Your guide to GLP-1 side

Im stuck

There are some rare but serious risks, like inflammation of the pancreas or thyroid concerns

In a press release, The Vitamin Shoppe president Muriel Gonzalez said, With the surge in GLP-1 medication use for weight loss, we recognized a critical gap in the market for tailored nutritional support

However, given the associated risks of cardiovascular disease and various cancers, the benefits of these medications, such as better glycemic control, weight loss and improvement in cardiometabolic risk factors as well as other obesity complications, appear to outweigh the risks for most adults with obesity [143, 153]